Conference item : Abstract
Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 105.9KB, Terms of use)
-
Authors
- Publisher:
- American Thoracic Society
- Host title:
- American Journal of Respiratory and Critical Care Medicine
- Journal:
- American Journal of Respiratory and Critical Care Medicine More from this journal
- Volume:
- 197
- Article number:
- A5959
- Publication date:
- 2018-12-01
- Acceptance date:
- 2018-06-01
- EISSN:
-
1535-4970
- ISSN:
-
1073-449X
- Subtype:
-
Abstract
- Pubs id:
-
pubs:950350
- UUID:
-
uuid:dfdc1a0f-9bc5-4480-ad3d-f982d02c1f60
- Local pid:
-
pubs:950350
- Source identifiers:
-
950350
- Deposit date:
-
2018-12-07
- ARK identifier:
Terms of use
- Copyright holder:
- American Thoracic Society
- Copyright date:
- 2018
- Notes:
- Presented at the American Thoracic Society 2018 International Conference, May 18-23, 2018 - San Diego, CA.
If you are the owner of this record, you can report an update to it here: Report update to this record